Eli Lilly and Co (NYSE:LLY)
| 196.88 BATS BZX Real-Time Price As of 1:28pm ET |  +1.94 / +0.99%Today’s Change | 129.21 Today|||52-Week Range 218.00 | +16.60% Year-to-Date |
LLY Regular Dividend: LLY began trading ex-dividend on 05/13/21. A $0.85 dividend will be paid to shareholders of record as of 05/14/21.
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 194.94 |
| Today’s open | 195.25 |
| Day’s range | 195.02 - 197.25 |
| Volume | 789,074 |
| Average volume (3 months) | 3,987,950 |
| Market cap | $187.4B |
Data as of 1:28pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | +0.69% |
| Earnings growth (next 5 years) | +12.30% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 29.5 |
| Price/Sales | 6.28 |
| Price/Book | 33.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -0.06 | -0.08% |
| NVSNovartis | +0.66 | +0.75% |
| ABBVAbbVie | +0.64 | +0.55% |
| PFEPfizer | +0.02 | +0.04% |
Data as of 1:29pm ET, 05/14/2021
Financials
| Next reporting date | August 3, 2021 |
| EPS forecast (this quarter) | $1.94 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
